DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
VCs - 1 — WeightWatchers - 1 Sari Kaganoff - 1 WeightWatchers - 1 it's - 1 Sima Sistani - 1 Noom - 1 Ro - 1
Top related locs:
Ozempic
Top related orgs:
Business - 1 Rock Health - 1 Web - 1 Getty - 1 PitchBook - 1

Search resuls for: "Saeju Jeong"


4 mentions found


☆ 3 titans will fight to dominate the market for Wegovy in 2024
  + stars: | 2023-12-27 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +5 min
Dozens of startups have jumped into the weight-loss market this year as weight-loss drugs, including Wegovy and Ozempic, have exploded in popularity. The few companies with enough money and brand recognition to stand up to Ozempic's distribution challenges — WeightWatchers, Noom, and Ro — can expect to compete for market dominance next year. But WeightWatchers signaled it's going all in on weight-loss drugs by launching its own behavioral program for patients on Ozempic in December. WeightWatchersLike WeightWatchers, Noom has remained staunchly in the weight-loss market since its 2008 launch. Ro launched its own program prescribing weight-loss drugs in January.
Persons: VCs, — WeightWatchers, Sari Kaganoff, WeightWatchers, it's, Sima Sistani, Noom, Ro, Zach Reitano, Kaganoff, Saeju Jeong, Sam Barnes, Aaron DeGagne Organizations: Business, Rock Health, Web, Getty, PitchBook Locations: Ozempic
☆ Noom quietly started writing prescriptions for trendy new weight-loss drugs
  + stars: | 2023-03-07 | by ( ) www.businessinsider.com   time to read: +4 min
The popular weight-loss app Noom quietly launched a new program that offers some users access to prescription anti-obesity medications. Called Noom Clinical, the program is meant to "build additional support" for app users, a company spokesperson said in a statement to Insider. Startups like Noom want to capitalize on a surge in demand for new weight-loss drugsSaeju Jeong, Co-founder & CEO, Noom Piaras Ó Mídheach/Sportsfile for Web Summit via Getty Images)Noom's foray into prescribing medication comes as demand for weight-loss drugs surges. NoomNoom, which introduced its weight loss app in 2017, is backed by venture firm Oak HC/FT and private-equity giant Silver Lake. According to the spokesperson, Noom began rolling out the new prescription-drug program to a small number of users in the fall.
☆ Noom sells psychology-driven weight loss — but former employees say they were unprepared for and overwhelmed by users' eating disorders, depression, and trauma
  + stars: | 2022-12-01 | by ( ) www.businessinsider.com   time to read: +31 min
Before joining Noom, users fill out a questionnaire asking about what diet programs or mental health apps they've used in the past. Very overly optimistic and happy, doesn't acknowledge what I'm really saying," one Noom user wrote on Reddit. Some of the coaches Insider interviewed said they were interacting with Noom users within two weeks of starting. Emotional bandwidthRachel Clair was hired as a Noom coach in 2018, at a time when the coaching staff grew from 60 to about 200. Annette Riedl/picture alliance via Getty ImagesIn October, 500 more Noom coaches were abruptly called into a virtual meeting and laid off.
☆ I tried the popular weight-loss app backed by Tony Xu and Scooter Braun. Keeping the weight off was harder than expected.
  + stars: | 2021-05-25 | by ( Lisa Rabasca Roepe | ) www.businessinsider.com   time to read: +10 min
Noom is a weight-loss app that uses a psychology-based approach to change your eating habits. One writer tried Noom for eight months to shed some pounds and prevent pandemic weight gain. In my latest attempt to lose weight, I turned to the Noom app. Lisa Rabasca RoepeI imagine that this is a powerful exercise for someone who has more than 10 pounds to lose. In fact, I've noticed that the people who have the most weight to lose have the most success with Noom.
0 next >>
Total: 4